Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. It was spun off from the British drugmaker ...

Pfizer Inc. is offering around 700 million shares in Haleon Plc, representing a roughly 7.7% stake in the maker of Sensodyne ...

Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK (GSK.L), opens new tab and Pfizer's consumer healthcare businesses in 2019. It was spun off from ...

Shares in the maker of Sensodyne, Panadol and Advil ... The sale represents nearly 7.7% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare ...

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for European expansion.

Consumer health care company Haleon plans to invest $54.2 million to upgrade its research and development facility in Richmond’s Northside.

Last October, it sold a $3.3 billion stake in the maker of Sensodyne, while GSK sold its entire stake in May. J.P. Morgan and Morgan Stanley are joint global coordinators and joint bookrunners for ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Weybridge, England-based Haleon is a consumer healthcare products manufacturer that owns brands such as Sensodyne toothpaste ... a joint venture of Pfizer and GSK PLC's consumer health businesses.